NIH #P50CA083636
Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women
- Amount
- $100K–$200K
- Period
- 2009-07-01 → 2014-06-30
- PIs
- 2
Awarded at FRED HUTCHINSON CANCER RESEARCH CENTER
Beth Y. Karlan
Full Professor(heuristic)
Ovarian cancer diagnosis and treatment · Reproductive Medicine
Compare more Reproductive Medicine professors.
h-index129
i10-index465
Publications1,114
Citations93,861
Grants
2 total · 0 active
NIH #M01RR000425
GENETIC FACTORS IN OVARIAN CANCER AMOUNG ASHKENAZI JEWISH WOMEN
- Amount
- <$100K
- Period
- 1997-12-01 → 1998-11-30
- PIs
- 1
Awarded at LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium (British Journal of Cancer)2026-06-29
- New preprint: The mutational landscape defines the proteome and spatial organization of tumor, stroma and immune cells in ovarian cancer2025-06-03
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0002-9451-2933